AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
TRICARE rules affecting beneficiary access to clinical laboratory services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JO ANNE GLISSON | — |
| JULIE A KHANI | — |
| SCOTT VAN BUREN MCGOOHAN | — |
| ALAN MERTZ | — |
| FRANCESCA FIERRO O'REILLY | — |
| THOMAS B SPARKMAN | — |
Health Issues HCR
Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including H.R.4302, the Protecting Access to Medicare Act of 2014, pricing for molecular diagnostic tests, and other items in the Final FY2015 PFS Rule. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the federal self-referral law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JO ANNE GLISSON | — |
| JULIE A KHANI | — |
| SCOTT VAN BUREN MCGOOHAN | — |
| ALAN MERTZ | — |
| FRANCESCA FIERRO O'REILLY | — |
| THOMAS B SPARKMAN | — |
Medicare/Medicaid MMM
Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including H.R.4302, the Protecting Access to Medicare Act of 2014, pricing for molecular diagnostic tests, and other items in the Final FY2015 PFS Rule. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the federal self-referral law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JO ANNE GLISSON | — |
| JULIE A KHANI | — |
| SCOTT VAN BUREN MCGOOHAN | — |
| ALAN MERTZ | — |
| FRANCESCA FIERRO O'REILLY | — |
| THOMAS B SPARKMAN | — |
Budget/Appropriations BUD
Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including H.R.4302, the Protecting Access to Medicare Act of 2014, pricing for molecular diagnostic tests, and other items in the Final FY2015 PFS Rule. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the federal self-referral law. TRICARE rules affecting beneficiary access to clinical laboratory services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JO ANNE GLISSON | — |
| JULIE A KHANI | — |
| SCOTT VAN BUREN MCGOOHAN | — |
| ALAN MERTZ | — |
| FRANCESCA FIERRO O'REILLY | — |
| THOMAS B SPARKMAN | — |
Medical/Disease Research/Clinical Labs MED
Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including H.R.4302, the Protecting Access to Medicare Act of 2014, pricing for molecular diagnostic tests, and other items in the Final FY2015 PFS Rule. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the federal self-referral law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JO ANNE GLISSON | — |
| JULIE A KHANI | — |
| SCOTT VAN BUREN MCGOOHAN | — |
| ALAN MERTZ | — |
| FRANCESCA FIERRO O'REILLY | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.